Smoking, Cigarette Clinical Trials
15 studies are recruiting for smoking, cigarette in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)
Lung cancer screening (LCS) with low-dose computed tomography (LDCT) can reduce the risk of dying from lung cancer, but many people who are eligible for screening do not receive it. The purpose of the Empower LCS/Call+ study is to evaluate new strategies to improve lung cancer screening among adult…
- Stage
- Not phased
- Ages
- 50 to 80
- Site
- UCI Health Family Health Center - Anaheim, Anaheim, California
- Locations
- 57 in total
- Run by
- University of California, Irvine
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
Trauma-informed approaches have been shown to support recovery from other substance use disorders and involve four key elements: (1) Realizing the prevalence of trauma and pathways to recovery, (2) Recognizing symptoms of trauma, (3) Responding by embedding knowledge of trauma into practices and po…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Zuckerberg San Francisco General Hospital, San Francisco, California
- Run by
- University of California, San Francisco
-
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey
- Locations
- 8 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
Maternal Smoking Cessation and Pediatric Obesity Prevention
The objective of this study is to test the effect of smoking cessation in pregnancy or in lactation on preventing rapid infant adiposity gain. Investigators propose a randomized, controlled experiment among smoking pregnant women from 1st prenatal care visit through 6 months of postpartum period. T…
- Stage
- Not phased
- Ages
- 18 to 39
- Site
- Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo, Buffalo, New York
- Run by
- State University of New York at Buffalo
-
Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion
The objective of this randomized controlled trial is to examine the efficacy of a new intervention to prevent postpartum smoking relapse and related health consequences through breastfeeding promotion. After the pre-test, ex-smokers who are still abstinent from smoking will be randomized into eithe…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo, Buffalo, New York
- Run by
- State University of New York at Buffalo
-
Cigarette Filter Study
The overall purpose of this study is to determine the effects of using charcoal-filtered cigarettes on product perceptions, smoking behaviors, and biomarkers of exposure to tobacco-related toxicants. The main questions it aims to answer are: Do perceptions of cigarettes differ by their filter? Do p…
- Stage
- Not phased
- Ages
- 21 and older
- Site
- Institute for Nicotine and Tobacco Studies, New Brunswick, New Jersey
- Run by
- Rutgers, The State University of New Jersey
-
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
The goal of this clinical trial is to learn if the drug semaglutide works to reduce alcohol intake among adults living with HIV. The main questions it aims to answer are: 1. Does semaglutide lower the average number of alcoholic beverages participants drink per week? 2. Does semaglutide lower the a…
- Stage
- Phase 2
- Ages
- 18 to 89
- Site
- Vanderbilt University Medical Center, Nashville, Tennessee
- Run by
- Vanderbilt University Medical Center
-
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
Mobile health (mHealth) will be used for early detection of oral cancer and pre-cancer lesions, and to improve awareness of oral cancer among the population and knowledge of oral cancer diagnosis among frontline health providers. This program is inclusive of long term surveillance to downstage oral…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York, New York
- Run by
- Memorial Sloan Kettering Cancer Center
-
Measuring Communal Coping in Dual-smoking Couples Making a Quit Attempt
Smoking is the leading preventable cause of death in the United States, and quitting is especially difficult for couples who both smoke. When both partners smoke, they are less likely to quit successfully and more likely to relapse compared to people whose partner does not smoke. Research suggests …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Colorado Denver, Denver, Colorado
- Run by
- University of Colorado, Denver
-
Dyadic Financial Incentive Treatments for Dual Smoker Couples
Smokers partnered with other smokers (i.e., dual-smoker couples) represent ~2/3 of all smokers. Dual-smoker couples (DSCs) are less likely to try to quit smoking and more likely to relapse during a quit attempt, reducing overall smoking cessation rates and representing a high-risk clinical populati…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- University of Oklahoma Health Campus, Tulsa, Oklahoma
- Locations
- 2 in total
- Run by
- University of Oklahoma
-
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
The goal of this clinical trial is to evaluate the effectiveness and implementation of a pharmacist-delivered MTM (medication therapy management) approach, called QuitAid, to quitting cigarette smoking in rural Appalachia. The main questions it aims to answer are: * Is QuitAid, alone or combined wi…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Virginia, Charlottesville, Virginia
- Run by
- University of Virginia
-
University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
The purpose of this study is to obtain new knowledge regarding screening for COPD. This study will use a participant's cancer screening CT scans performed as part of routine health care among current and former smokers at risk for COPD to identify participants who have had a spirometry or will have…
- Stage
- Not phased
- Ages
- 50 to 80
- Site
- University of Michigan, Ann Arbor, Michigan
- Run by
- University of Michigan
-
ACT Lung Health Intervention: Phase Two
This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- Dana-Farber Cancer Institute, Boston, Massachusetts
- Locations
- 2 in total
- Run by
- Dana-Farber Cancer Institute
-
Optimizing Tobacco Treatment Delivery for People Living With HIV
The purpose of this study is to conduct a randomized trial to evaluate a proactive, opt-out model of provider contact to deliver smoking cessation support for people living with HIV compared to standard care support delivered through traditional clinic pathways. Investigators will also evaluate imp…
- Stage
- Not phased
- Ages
- 21 and older
- Site
- Medical University of South Carolina, Charleston, South Carolina
- Run by
- Medical University of South Carolina
-
Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation
The purpose of this research is to measure the extent of lung inflammation between different groups of participants using a radioactive tracer called [18F]NOS. A radioactive tracer is a type of imaging drug that is labeled with a radioactive tag and injected into the body.
- Stage
- Phase 1
- Ages
- 18 to 45
- Site
- University of Pennsylvania, Philadelphia, Pennsylvania
- Run by
- University of Pennsylvania
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.